R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Director - National Portfolio Field Excellence

Sales OperationsPosted on Nov 9
Full-timeRemote in USARemote

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 12 years of progressive commercial experience in the pharmaceutical or biotechnology industry, combining field sales leadership with commercial or field operations.
  • Prior second-line field sales leadership at the Regional Business Director level or equivalent, leading first-line managers.
  • Oncology experience, including buy-and-bill or intravenous oncology products.
  • Product launch experience, including new indications or portfolio expansion.
  • Experience in both a large, established pharmaceutical organization and a smaller, high-growth biotechnology environment.
  • Ability to build an operating model from scratch in a launch or early commercial setting and to manage and develop a team.
  • A track record of partnering at the Executive Director or Vice President level inside a sales hierarchy, not only supporting sales from headquarters.
  • Strong analytical capability to build and run a business review framework and interpret results.

Responsibilities

  • Jointly develop and evolve the Portfolio Field Excellence operating model with Sales Operations & Analytics, including shared priorities, decision rights, governance, and protocols.
  • Serve as a portfolio-level business partner to senior Sales Leadership on field execution priorities, market dynamics, and portfolio coordination.
  • Jointly manage the field-intelligence loop with Sales Operations & Analytics by identifying recurring field patterns, prioritizing portfolio solutions, and closing the loop with field leadership.
  • Lead business-facing standards and leadership forums for consistent field execution across tumor-specific field teams, shared accounts, and common ways of working.
  • Establish account-planning standards, templates, and governance with Sales Leadership and portfolio partners; partner with Sales Operations & Analytics on planning tools, customer relationship management workflows, adoption, and target and alignment refinement.
  • Partner on business-review standards, leadership cadence, action follow-through, and performance narratives across field leadership levels; partner with Sales Operations & Analytics on key performance indicators, reporting, analytical inputs, and workflows.
  • Partner with Sales Operations & Analytics and Analytics & Insights to ensure account-level and regional performance analysis captures local context and supports field action.
  • Lead the portfolio business-readiness model for new indications and field teams, including readiness expectations, leadership alignment, and launch-cycle integration.
  • Partner with Sales Operations & Analytics on operational readiness across field systems, customer relationship management, field alerts, incentive compensation, reporting, planning, and readiness tracking.
  • Own the strategy, governance, cadence, and channels for field communications, including clear, consistent, and compliant direction and guidance for field teams.
  • Manage approval, dissemination, storage, and refresh of field direction and guidance documents in partnership with Legal, Regulatory, and Compliance.
  • Lead planning and execution of national, area, and regional field meetings, including launch and plan-of-action meetings, in partnership with Sales Leadership and Commercial Learning, Training & Development.
  • Coordinate portfolio-level connectivity across field teams to support shared customers, launches, and evolving commercial priorities.
  • Lead a team responsible for end-to-end commercial congress execution across the portfolio, including planning, field deployment, customer engagement plans, on-site operations, and post-congress follow-up.
  • Oversee Speaker Bureau program operations, including speaker nomination and contracting, logistics, program execution, compliance, and reporting.
  • Oversee commercial sponsorships and congress operations, including budget, contracting, and coordination with Legal and Compliance.
  • Through the Associate Director, Portfolio Operational Excellence, lead operating standards, vendor governance, and continuous improvement for commercial programs within this role's remit; partner with Sales Operations & Analytics where field systems, analytics, operations, or program execution intersect.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs